Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer

Urology

Volumn 54, Issue 1, 1999, Pages 111-117

  Vicini, Frank A ^a   Ziaja, Ellen L ^a   Kestin, Larry L ^a   Brabbins, Donald S ^a   Stromberg, Jannifer S ^a   Gonzalez, Jose A ^a   Martinez, Alvaro A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SALVAGE THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 0033168704     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00219-8     Document Type: Article

References (39)

1. Schild SE: Radiation therapy after prostatectomy: now or later? Semin Radiat Oncol 8: 132-139, 1998.
2. Forman JD, and Velasco J: Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology 12: 33-47, 1998.
3. Zietman AL: When should radiation therapy follow radical prostatectomy in the management of prostatic cancer? Mayo Clin Proc 69: 700-701, 1994.
4. Takayama TK, and Lange PH: Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol Clin North Am 21: 687-700, 1994.
5. Anscher MS: Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution? Int J Radiat Oncol Biol Phys 34: 745-747, 1996.
6. Andriole AL: Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy. Eur Urol 32(suppl 3): 65-69, 1997.
7. American Joint Committee on Cancer: Prostate, in Bearhrs OH, Henson DR, Hutter RVP, et al (Eds): AJCC Cancer Staging Manual, 4th ed. Philadelphia, JB Lippincott, 1992, pp 181-186.
8. Kaplan EL, and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
9. Mantel N, and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.
10. Cadeddu JA, Partin AW, DeWeese TL, et al: Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 159: 173-178, 1998.
11. Haab F, Delmas V, Meulemans A, et al: Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay. Urology 45: 1022-1027, 1995.
12. Medini E, Medini I, Reddy PK, et al: Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. Cancer 78: 1254-1259, 1996.
13. Forman JD, Meetze K, Pontes E, et al: Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 158: 1436-1440, 1997.
14. Vander Kooy MJ, Pisansky TM, Cha SS, et al: Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. Urology 49: 65-70, 1997.
15. Schild SE, Buskirk SJ, Wong WW, et al: The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol 156: 1725-1729, 1996.
16. Wu JJ, King SC, Montana GS, et al: The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. IntJ Radiat Oncol Biol Phys 32: 317-323, 1995.
17. Lange PH, Lightner DJ, Medini E, et al: The effect of radiation therapy after radical prostatectomy in patients with elevated prostate-specific antigen levels. J Urol 144: 927-933, 1990.
18. Hudson MA, and Catalona WJ: Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J Urol 143: 1174-1177, 1990.
19. Link P, Freiha FS, and Stamey TA: Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532-534, 1991.
20. Raymond JF, Vuong M, and Russell KJ: Neutron beam radiotherapy for recurrent prostate cancer following radical prostatectomy. IntJ Radiat Oncol Biol Phys 41: 93-99, 1998.
21. Valicenti RK, Gomella LG, Ismail M, et al: Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma. Cancer 82: 1909-1914, 1998.
22. Coetzee LJ, Hars V, and Paulson DF: Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Urology 47: 232-235, 1996.
23. Zietman AL, Coen JJ, Shipley WU, et al: Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure. Urology 42: 292-298, 1993.
24. Petrovich Z, Lieskovsky G, Freeman J, et al: Surgery with adjuvant irradiation in patients with pathologic stage C adenocarcinoma of the prostate. Cancer 76: 1621-1628, 1995.
25. Yamada AH, Lieskovsky G, Petrovich Z, et al: Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Am J Clin Oncol 17: 277-285, 1994.
26. Petrovich Z, Lieskovsky G, Langholz B, et al: Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate. Int J Radiat Oncol Biol Phys 40: 139-147, 1998.
27. Weigel T, Bressel M, and Carl UM: Adjuvant radiotherapy following radical prostatectomy - results of 56 patients. EurJ Cancer 31A: 5-11, 1995.
28. Buskirk SJ, Schild SE, Durr ED, et al: Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, N0 prostate cancer. Mayo Clin Proc 71: 242-248, 1996.
29. Morgan WR, Zincke H, Rainwater LM, et al: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol 145: 319-323, 1991.
30. Stein A, DeKernion JB, and Dorey G: Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through the capsule or positive seminal vesicles. Urology 39: 59-62, 1992.
31. Crane CH, Rich TA, Read PW, et al: Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. Int J Radiat Oncol Biol Phys 39: 681-686, 1997.
32. Morris MM, Dallow KC, Zietman AL, et al: Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 38: 731-736, 1997.
33. McCarthy JF, Catalona WJ, and Hudson MA: Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J Urol 151: 1575-1578, 1994.
34. Syndikus J, Pickles T, Kostashuk E, et al: Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. J Urol 155: 1983-1986, 1996.
35. Anscher MS, Robertson CN, and Prosnitz LR: Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update. Int J Radiat Oncol Biol Phys 33: 37-43, 1995.
36. Schild SE, Wong WW, Grado GL, et al: The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 34: 535-541, 1996.
37. Meier R, Mark R, St. Royal L, et al: Postoperative radiation therapy after radical prostatectomy for prostate cancer. Cancer 70: 1960-1966, 1992.
38. Eisbruch A, Perez CA, Roessler EH, et al: Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 73: 384-387, 1994.
39. Elias S, Parker RG, Gallardo D, et al: Adjuvant radiation therapy after radical prostatectomy for carcinoma of the prostate. Am J Clin Oncol 20: 120-124, 1997.